| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.13▲ | 1.14▲ | 1.14▲ | 1.13▲ | 1.15▼ |
| MA10 | 1.15▼ | 1.15▼ | 1.15▼ | 1.15▼ | 1.22▼ |
| MA20 | 1.18▼ | 1.18▼ | 1.19▼ | 1.15▼ | 1.20▼ |
| MA50 | 1.27▼ | 1.27▼ | 1.28▼ | 1.25▼ | 1.78▼ |
| MA100 | 1.33▼ | 1.29▼ | 1.29▼ | 1.20▼ | 2.26▼ |
| MA200 | 1.27▼ | 1.25▼ | 1.22▼ | 1.49▼ | 9.76▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▼ | -0.001▼ | -0.002▼ | 0.002▲ | 0.027▲ |
| RSI | 42.876▼ | 42.837▼ | 42.263▼ | 42.951▼ | 43.145▼ |
| STOCH | 11.786▼ | 22.897 | 23.115 | 33.793 | 23.690 |
| WILL %R | -77.273▼ | -70.833 | -75.000▼ | -72.091 | -78.825▼ |
| CCI | -39.080 | -33.880 | -37.890 | -84.445 | -84.743 |
|
Wednesday, June 18, 2025 06:00 AM
Akari Therapeutics announced a new patent for its PH1 cancer treatment, enhancing immuno-oncology ADC technology in India.
|
|
Monday, June 16, 2025 05:01 PM
Abizer Gaslightwala, the President & CEO of $AKTX, bought 15,000 shares of the company on 06-17-2025 for an estimated $18,000.
|
|
Wednesday, June 11, 2025 01:55 AM
The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 11/07/25 | 1.14 | 1.15 | 1.11 | 1.1307 | 16,882 |
| 10/07/25 | 1.1297 | 1.145 | 1.1245 | 1.145 | 6,165 |
| 09/07/25 | 1.1253 | 1.14 | 1.1015 | 1.1265 | 35,852 |
| 08/07/25 | 1.1209 | 1.135 | 1.12 | 1.12 | 6,017 |
| 07/07/25 | 1.1643 | 1.17 | 1.11 | 1.11 | 14,407 |
| 03/07/25 | 1.14 | 1.17 | 1.14 | 1.17 | 2,252 |
| 02/07/25 | 1.17 | 1.1816 | 1.10 | 1.155 | 35,660 |
| 01/07/25 | 1.18 | 1.18 | 1.16 | 1.165 | 7,101 |
| 30/06/25 | 1.1579 | 1.18 | 1.1579 | 1.1699 | 8,221 |
| 27/06/25 | 1.1655 | 1.20 | 1.15 | 1.1591 | 29,569 |
|
|
||||
|
|
||||
|
|